Replies to post #173 on Argent Biopharma Ltd (MGCLF)

[BostonErin]

They do have less shares that’s why their about $8. Divide market cap by outstanding shares and that’s your pps. Aurora was closest to the quarterly number that I came to for MGC so I looked at their market cap and it was $4bil at the time I ran the numbers. If mgc gets 4bil m/c. That puts us about $3.80. Which I think is doable if the multiplier on the revenue stays the same in cannabis (I believe it’s about 10xrevenue now)

Hope that makes sense.... I’m a math person lol

[BostonErin]

This is where I got the quarterly on Aurora- New Cannabis Ventures

Company Name Stock Symbol Quarter Ended Quarterly Sales Y/Y Growth Next Financials
Canopy Growth (TSX: WEED) 12/31/17 C$21.7m 123% ~06/29/18
Aurora Cannabis (TSX: ACB) 12/31/17 C$11.7m 201% ~05/15/18
MedReleaf (TSX: LEAF) 12/31/17 C$11.35m 9% ~06/29/18
Aphria (TSX: APH) 11/30/17 C$8.50m 63% ~04/16/18
CannTrust